Who publishes list of bacteria for which new antibiotics are urgently needed
01 Apr 2017-Vol. 22, Iss: 2, pp 159-160
TL;DR: The list was drawn up in a bid to guide and promote research and development (R&D) of new antibiotics as discussed by the authors, which is the first ever list of antibiotic-resistant "priority pathogens".
Abstract: 27 FEBRUARY 2017 | GENEVA - WHO today published its first ever list of antibiotic-resistant “priority pathogens” – a catalogue of 12 families of bacteria that pose the greatest threat to human health.
The list was drawn up in a bid to guide and promote research and development (R&D) of new
Citations
More filters
TL;DR: How the modern scientific community works to improve the reliability and success ofphage therapy in the clinic is explored and how to properly evaluate the potential for phage therapy to combat antibiotic-resistant bacteria is discussed.
551 citations
TL;DR: The analysis of antibiotic contamination-driven resistance in global rivers provides a clear picture of the consequences in the near future, and integrons and mobile genetic elements are suggested as one of the important media for resistance gene transfer.
255 citations
TL;DR: Cefiderocol, a novel parenteral siderophore cephalosporin conjugated with a catechol moiety, has a characteristic antibacterial spectrum with a potent activity against a broad range of aerobic Gram-negative bacterial species, including carbapenem-resistant strains of Enterobacteriaceae and nonfermenting bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii.
Abstract: Cefiderocol (CFDC; S-649266), a novel parenteral siderophore cephalosporin conjugated with a catechol moiety, has a characteristic antibacterial spectrum with a potent activity against a broad range of aerobic Gram-negative bacterial species, including carbapenem-resistant strains of Enterobacteriaceae and nonfermenting bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii Cefiderocol has affinity mainly for penicillin-binding protein 3 (PBP3) of Enterobacteriaceae and nonfermenting bacteria similar to that of ceftazidime. A deficiency of the iron transporter PiuA in P. aeruginosa or both CirA and Fiu in Escherichia coli caused 16-fold increases in cefiderocol MICs, suggesting that these iron transporters contribute to the permeation of cefiderocol across the outer membrane. The deficiency of OmpK35/36 in Klebsiella pneumoniae and the overproduction of efflux pump MexA-MexB-OprM in P. aeruginosa showed no significant impact on the activity of cefiderocol.
212 citations
TL;DR: Different aspects of resistance and pathogenicity in P. aeruginosa, such as the role of outer membrane proteins, transcriptional regulators, efflux pumps, enzymes, and biofilms in antimicrobial resistance, are highlighted.
183 citations
TL;DR: Though OECD countries have substantially lower pooled prevalence of resistance compared to non-OECD countries based on the data during 2006–2016, a further investigation in a time scale disclosed a faster increase in OECD countries during the past 11 years, and currently both of them have a comparable prevalence of resistances.
Abstract: Acinetobacter baumannii is one of the most challenging nosocomial pathogens due to the emergence and widespread of antibiotic resistance. We aimed to provide the first analysis of global prevalence...
120 citations